Arkolith/Insider Trading/CARM/Form 4

Klichinsky Michael

Chief Scientific OfficerCarisma Therapeutics Inc. (CARM) · full profile →Form 4 · filed Mar 9, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 7, 2023Grant(A)484K——484K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 7, 2023Grant(A)112K——112K
Mar 7, 2023Grant(A)57K——57K
Mar 7, 2023Grant(A)76K——76K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-030750) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML